- Home
- VRNA vs SGRY Comparison
VRNA vs SGRY Comparison
Compare VRNA & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- SGRY
- Stock Information
- Founded
- VRNA 2005
- SGRY 2004
- Country
- VRNA United Kingdom
- SGRY United States
- Employees
- VRNA N/A
- SGRY N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- SGRY Hospital/Nursing Management
- Sector
- VRNA Health Care
- SGRY Health Care
- Exchange
- VRNA Nasdaq
- SGRY Nasdaq
- Market Cap
- VRNA 3.2B
- SGRY 2.7B
- IPO Year
- VRNA 2017
- SGRY 2015
- Fundamental
- Price
- VRNA $43.06
- SGRY $21.17
- Analyst Decision
- VRNA Strong Buy
- SGRY Buy
- Analyst Count
- VRNA 6
- SGRY 9
- Target Price
- VRNA $43.83
- SGRY $37.38
- AVG Volume (30 Days)
- VRNA 1.0M
- SGRY 1.4M
- Earning Date
- VRNA 11-04-2024
- SGRY 11-12-2024
- Dividend Yield
- VRNA N/A
- SGRY N/A
- EPS Growth
- VRNA N/A
- SGRY N/A
- EPS
- VRNA N/A
- SGRY N/A
- Revenue
- VRNA $5,624,000.00
- SGRY $2,985,300,000.00
- Revenue This Year
- VRNA N/A
- SGRY $14.46
- Revenue Next Year
- VRNA $644.06
- SGRY $9.94
- P/E Ratio
- VRNA N/A
- SGRY N/A
- Revenue Growth
- VRNA 1127.95
- SGRY 9.96
- 52 Week Low
- VRNA $11.39
- SGRY $19.90
- 52 Week High
- VRNA $43.73
- SGRY $35.30
- Technical
- Relative Strength Index (RSI)
- VRNA 61.99
- SGRY 36.00
- Support Level
- VRNA $38.77
- SGRY $19.90
- Resistance Level
- VRNA $43.73
- SGRY $22.35
- Average True Range (ATR)
- VRNA 1.41
- SGRY 1.08
- MACD
- VRNA 0.07
- SGRY 0.10
- Stochastic Oscillator
- VRNA 60.80
- SGRY 24.46
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.